Immunoprecise Antibodies Stock Options Expiring on 19th of January 2024

IPA
 Stock
  

USD 4.14  0.15  3.50%   

There are currently no option contracts on Immunoprecise Antibodies for investors to trade. Please select a different company on which options are written by Market Makers and option chain is available.
Immunoprecise Antibodies' latest option contracts expiring on 2024-01-19 are carrying combined implied volatility of 135.14 with a put-to-call open interest ratio of 0.05 over 8 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-01-19. The current put volume is at 50, with calls trading at the volume of 255. This yields a 0.2 put-to-call volume ratio. The Immunoprecise Antibodies option chain provides detailed quote and price information for the current Immunoprecise Antibodies option contracts. It shows all of Immunoprecise Antibodies' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2024-01-19 Option Contracts

Immunoprecise Antibodies option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Immunoprecise Antibodies' lending market. For example, when Immunoprecise Antibodies' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Immunoprecise Antibodies, he or she must hedge the risk by shorting Immunoprecise Antibodies stock over its option's life.
The chart above shows Immunoprecise Antibodies' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Immunoprecise Antibodies' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Immunoprecise Antibodies' option, there is no secondary market available for investors to trade.

Immunoprecise Antibodies Maximum Pain Price across 2024-01-19 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Immunoprecise Antibodies close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Immunoprecise Antibodies' stock options are financial instruments that give investors the right to buy or sell shares of Immunoprecise Antibodies common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Immunoprecise stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Immunoprecise Antibodies' stock price goes up or down, the stock options follow.
Please see Risk vs Return Analysis.
Please note that buying 'in-the-money' options on Immunoprecise Antibodies lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Immunoprecise Antibodies' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Immunoprecise Antibodies contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Immunoprecise Stock moves the wrong way.
As of June 27, 2022, Net Income Common Stock is expected to decline to about (9.1 M)

Immunoprecise Current Options Market Mood

Immunoprecise Antibodies' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Immunoprecise Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Immunoprecise Antibodies' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Immunoprecise Antibodies' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Immunoprecise Antibodies' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Immunoprecise contract

Base on the Rule 16, the options market is currently suggesting that Immunoprecise Antibodies will have an average daily up or down price movement of about 8.45% per day over the life of the 2024-01-19 option contract. With Immunoprecise Antibodies trading at $4.14, that is roughly $0.35. If you think that the market is fully incorporating Immunoprecise Antibodies' daily price movement you should consider buying Immunoprecise Antibodies options at the current volatility level of 135.14%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Immunoprecise Antibodies Option Chain

When Immunoprecise Antibodies' strike price is surpassing the current stock price, the option contract against Immunoprecise Antibodies stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2022-07-152022-08-192022-11-182023-01-202023-02-172024-01-19
Immunoprecise Antibodies' option chain is a display of a range of information that helps investors for ways to trade options on Immunoprecise. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Immunoprecise. It also shows strike prices and maturity days for a Immunoprecise Antibodies against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2024-01-19 CALL at $7.50.82220.02718262024-01-190.0 - 5.02.57Out
Call
2024-01-19 CALL at $10.00.79550.0298872024-01-190.0 - 5.02.22Out
Call
2024-01-19 CALL at $12.50.37030.078416852024-01-190.35 - 1.10.94Out
 Put
2024-01-19 PUT at $5.0-0.32620.0744202024-01-190.0 - 4.72.05In
 Put
2024-01-19 PUT at $10.0-0.69020.0925502024-01-194.1 - 8.36.3In
 Put
2024-01-19 PUT at $12.5-0.31580.04271402024-01-196.0 - 10.29.4In

Immunoprecise Antibodies Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
 Net Income Common Stock 
Share
      Timeline 

Immunoprecise Antibodies Net Income Common Stock USD Over Time

Net Income Common Stock in USD; converted by US Dollar Exchange Rate.
 Net Income Common Stock USD 
Share
      Timeline 

Immunoprecise Antibodies Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of Immunoprecise Antibodies, understanding its historical liability is critical in projecting Immunoprecise Antibodies' future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how Immunoprecise Antibodies uses its financing power over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
98 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.